Skip to content

Empowering Narratives

Styrkende Narrativ: Hjelp Til Selvhjelp for Ukrainske Flyktninger / Empowering Narratives: Help to Self-help to Ukrainian Refugees

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07062042
Acronym
EN
Enrollment
50
Registered
2025-07-14
Start date
2025-03-01
Completion date
2026-04-20
Last updated
2025-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression Disorders, Dissociation, PTSD - Post Traumatic Stress Disorder, Refugee

Keywords

PTSD, Depression Disorders, Dissociation, Ukrainian Refugees, Norway, Narrative Exposure Therapy

Brief summary

Background: The Russian invasion of Ukraine has resulted in forced displacement, with over 80,000 Ukrainian refugees now residing in Norway. This displacement has led to increased vulnerability to trauma and mental health challenges. Narrative Exposure Therapy (NET), a short-term trauma-focused intervention, has demonstrated efficacy in reducing PTSD symptoms among individuals exposed to organized violence and war. Aim: The protocol aims to assess the clinical effects of Narrative Exposure Therapy (NET) on PTSD and depression symptoms among Ukrainian refugees in Norway and to facilitate training and supervised practice for Ukrainian health professionals and workers in using NET. Methods: This study employs a pretest-posttest randomized controlled experimental design. Ukrainian health professionals and workers in Norway will receive standardized NET training through a digital course. Subsequently, they will treat Ukrainian refugees using NET under supervision. Participants will be screened and assessed at three time points: baseline, immediately after treatment, and at 6-month follow-up. Validated questionnaires in Ukrainian and Russian will be used: PHQ-9, ITQ, LEC-5, SHUT-D, and demographic questionnaire. Exclusion criteria include active psychotic spectrum disorders, neurodevelopmental disorders and concurrent trauma therapy.

Detailed description

Ethical Approval: The study received ethical approval from the Regional Committees for Medical and Health Research Ethics - South-East D (REK sør-øst D) in Norway, under reference number 790305. Quality Assurance and Data Management: The proposed study will not use any registry data and instead collect data with validated questionnaires. Questionnaires will be filled in during interviews with the NET therapist, which will increase data quality by ensuring that participants understand the questions and are engaged in answering them. The questionnaires were translated to Ukrainian by the Trauma Consortium, which helps to ensure both quality and understanding from both patients and health workers. Questionnaire data will be coded in accordance with the published manuals for the respective questionnaires, and a data dictionary will be used to describe each variable according to the manuals. All data, including notes from NET sessions and the resulting narratives, will be stored on a secure server, TSD (link to the website can be found in the reference list). Questionnaire data will be collected with a secure and anonymous data collection tool, Nettskjema (link to the website can be found in the reference list), and will be directly transferred to TSD. The study will also include a link key, stored in TSD, that links the participant's name to an anonymous code, and the anonymous code to the dataset, so that data will not be stored together with the participants' names. The data management in the current study has been assessed with a Data Protection Impact Assessment (DPIA) and has been approved by the Norwegian Agency for Shared Services in Education and Research, SIKT (link to the website in the reference list) and the Norwegian Regional Committee for Medical and Health Research Ethics, REK (link to the website can be found in the reference list). REK also approved an emergency procedure for handling cases where participants score highly on depression or suicidal thoughts. The procedure includes a psychoeducative conversation with the participants by the project's PI (Vanessa Nolasco Ferreira) and the offer to send a letter to the participant's General Practitioner, with information about the depression and/or suicidal thoughts score. This letter will allow the GP to refer the participant to the specialized mental health services and reduce waiting times for treatment. Sample Size Assessment: A convenience sampling approach will be utilized, with the final sample size depending on the number of individuals who volunteer and meet the inclusion criteria. This approach accommodates variability in participant availability and willingness. The project has financial resources for NET training of 25 health workers, and each health worker needs to conduct supervised NET with two participants as part of the practical training that is necessary for NET certification. We are therefore aiming at 50 participants (25 in the intervention group and 25 in the waitlist control group). Previous NET interventions in similar populations have shown significant effects with comparable or considerably smaller sample sizes. Plan for Missing Data: The dropout rate during NET interventions tends to be low or zero, partially due to the short duration of interventions. Therefore, we expect minimal risk of missing datasets at post-treatment assessments. There might be a slightly higher risk for missing datasets at 6-months follow-up. We will compare demographic data and initial post-treatment effects of any dropouts with data of participants that complete the follow-up assessment, in order to evaluate potential biases due to systematic differences between dropouts and completers. There is no risk of missing data due to incomplete questionnaires (i.e. participants accidentally not answering single items) since the software used for assessment does not allow submission of the questionnaire unless all items are answered.

Interventions

BEHAVIORALNarrative Exposure Therapy

Narrative Exposure Therapy (NET) is a short-term, trauma-focused intervention developed for individuals exposed to multiple traumatic events, including refugees and survivors of war and organized violence. It is grounded in principles of cognitive-behavioral therapy and testimonial therapy. NET helps adults reconstruct a coherent narrative of their life by integrating fragmented traumatic memories through structured exposure within a chronological autobiographical framework. Core components include lifeline construction, imaginal exposure to traumatic events, and reprocessing of emotional responses. The method emphasizes stabilization through therapeutic structure and is supported by evidence from randomized controlled trials showing reductions in PTSD symptoms. The approach is protocol-driven and applicable in low-resource settings under supervision, as outlined in the practice document.

Sponsors

University of Konstanz
CollaboratorOTHER
Oswaldo Cruz Foundation
CollaboratorOTHER
Mental helse
CollaboratorUNKNOWN
Vårsta Diakoni
CollaboratorUNKNOWN
Norsk-Ukrainsk hjelpeorganisasjon
CollaboratorUNKNOWN
The Dam Foundation
CollaboratorOTHER
Kristiania University College
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

This study utilizes a parallel-group randomized controlled trial design. Participants will be randomly assigned to one of two groups: an intervention group, which will receive Narrative Exposure Therapy (NET), and a waitlist control group, which will receive treatment after the initial study period (when the post-treatment screening of the participant that is matching case for each control case is concluded). Quantitative data will be collected from both groups using a repeated screening measures approach. For the intervention group, data will be gathered at three timepoints: (1) baseline (prior to treatment), (2) post-treatment (approximately one week after the final session), and (3) follow-up (six months after treatment completion). For the control group, data will be collected at two timepoints: (1) baseline, and (2) after a waiting period equivalent in length to the intervention group's treatment phase, prior to their own treatment onset.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Ukrainian refugee residing in Norway. * Arrival in Norway after 24 February 2022. * Minimum 18 years old * Provided informed consent for participation. * Classified as having PTSD symptoms (ITQ) OR reported traumatic experience (LEC-5) OR present PTSD comorbidities (PHQ-9, Shut-D).

Exclusion criteria

* Diagnosis, history, or scores compatible with the psychotic spectrum * Diagnostic of neurodevelopmental disorders * Current participation in ongoing trauma-focused psychological treatment (e.g., therapy for PTSD). * Declining consent for mandatory elements of the study (e.g., participation in screening or treatment delivery).

Design outcomes

Primary

MeasureTime frameDescription
PTSD Symptom Severity (ITQ)Baseline, Post-treatment (one to seven days after the last treatment session), 6-month Follow-up (counted after the post-treatment screening)Assesses symptoms of PTSD and Complex PTSD, including re-experiencing, avoidance, threat perception, and functional impairment. Instrument: International Trauma Questionnaire (ITQ) Outcome Focus: Change in PTSD symptom scores over time (H1, H4)
Dissociation Symptoms (Shut-D)Baseline, Post-treatment (one to seven days after the last treatment session), 6-month Follow-up (counted after the post-treatment screening)Measures dissociative responses specific to trauma, including cognitive-emotional shutdown, sensory-motor dissociation, and behavioral shutdown. Instrument: Shutdown Dissociation Scale (Shut-D) Outcome Focus: Change in dissociation symptom scores over time (H2, H5)
Depression Symptoms (PHQ-9)Baseline, Post-treatment (one to seven days after the last treatment session), 6-month Follow-up (counted after the post-treatment screening)Measures the frequency of depressive symptoms over the past two weeks, including somatic and cognitive-affective dimensions, plus functional impairment. Instrument: Patient Health Questionnaire-9 (PHQ-9) Outcome Focus: Change in depressive symptoms (H3, H6)

Secondary

MeasureTime frameDescription
Exposure to Traumatic Events (LEC-5)BaselineCaptures direct and indirect exposure to 17 categories of potentially traumatic events, including whether the event happened to me. Instrument: Life Events Checklist for DSM-5 (LEC-5) Association between level of trauma exposure and symptom severity (H7)

Other

MeasureTime frameDescription
Long-term illness, health problem or handicapBaselineYes or No
General Perception of HealthBaselineVery good; Good ; Fair; Poor; Very poor.
AgeBaselineAge in years
Functional ImpairmentBaseline, Post-treatment (one to seven days after the last treatment session), 6-month Follow-up (counted after the post-treatment screening)In the international trauma questionaire function impairment connected to PTSD is measured if At least one of P7, P8, or P9 \> 2 meets criteria for PTSD functional impairment (PTSDFI) If the patient meets the criteria for CPTSD the function impairment is measured if at least one of C7, C8, or C9 \> 2 meets criteria for DSO functional impairment (DSOFI) In what concerns depression, the measure will come from the question number 10 in PHQ9 if the patient answers somewhat difficult, difficult or very difficult. Embedded in: ITQ and PHQ-9 Outcome Focus: Supplementary analysis of clinical relevance
Time in NorwayBaselinePatient reports during the first therapy session (lifeline session)
GenderBaselineMale, Female
Marital statusBaselineSingle, have never been married; Married/co-habiting; Divorced/separated - within last year; Divorced/separated - for more than 1 year; Widow/Widower - within last year; Widow/Widower - for more than 1 year. Analytical Use: Covariates or moderators in outcome models
EducationBaselinePrimary (less than 7 grades); Incomplete secondary (less than 10 grades); Trade factory apprenticeship or professional courses after 7-8 grades; Completed secondary (10-11 grades); Trade factory apprenticeship or professional courses after 10-11 grades; Secondary technical education; Uncompleted higher education (3 courses or less); Completed higher education. Instrument: Custom questionnaire Analytical Use: Covariates or moderators in outcome models

Countries

Norway

Contacts

Primary ContactVanessa Nolasco Ferreira, Associate Professor, PhD
vanessanolasco.ferreira@kristiania.no+4741231069
Backup ContactAshley Rebecca Bell-Mizori, Master in Psychology
vanessanolasco.ferreira@kristiania.no

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026